KAI1 inhibits HGF-induced invasion of pancreatic cancer by sphingosine kinase activity

Jemal, 2010, Cancer statistics, 2010, CA Cancer J Clin, 60, 277, 10.3322/caac.20073 Chames, 2010, Therapeutic antibodies for the treatment of pancreatic cancer, Scientific World Journal, 10, 1107, 10.1100/tsw.2010.103 Klapman, 2008, Early detection of pancreatic cancer: why, who, and how to screen, Cancer Control, 15, 280, 10.1177/107327480801500402 Kauffman, 2003, Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site, J Urol, 169, 1122, 10.1097/01.ju.0000051580.89109.4b Malik, 2009, KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis, Histol Histopathol, 24, 519 Yáñez-Mó, 2009, Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes, Trends Cell Biol, 19, 434, 10.1016/j.tcb.2009.06.004 Miranti, 2009, Controlling cell surface dynamics and signaling: how CD82/KAI1 suppresses metastasis, Cell Signal, 21, 196, 10.1016/j.cellsig.2008.08.023 Lazo, 2007, Functional implications of tetraspanin proteins in cancer biology, Cancer Sci, 98, 1666, 10.1111/j.1349-7006.2007.00584.x Dong, 1995, KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2, Science, 268, 884, 10.1126/science.7754374 Friess, 1998, Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant métastases, Int J Cancer, 79, 349, 10.1002/(SICI)1097-0215(19980821)79:4<349::AID-IJC7>3.0.CO;2-V Guo, 1998, KAI1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers, Cancer Res, 58, 753 Guo, 2005, Current diagnosis and treatment of pancreatic cancer in China, Pancreas, 31, 13, 10.1097/01.mpa.0000168220.97967.d1 Pyne, 2010, Sphingosine 1-phosphate and cancer, Nat Rev Cancer, 10, 489, 10.1038/nrc2875 Leong, 2010, S1P metabolism in cancer and other pathological conditions, Biochimie, 92, 716, 10.1016/j.biochi.2010.02.014 Takabe, 2008, “Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets, Pharmacol Rev, 60, 181, 10.1124/pr.107.07113 Mu, 2008, Guo X KAI1/CD82 suppresses hepatocyte growth factor-induced migration of hepatoma cells via upregulation of Sprouty2, Sci China C Life Sci, 51, 648, 10.1007/s11427-008-0086-1 Pipiya, 2005, Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression, Gene Ther, 12, 911, 10.1038/sj.gt.3302459 Gregory, 2003, Enhancement of adenovirus-mediated gene transfer to the airways by DEAE dextran and sodium caprate in vivo, Mol Ther, 7, 19, 10.1016/S1525-0016(02)00021-7 Heilbronn, 2010, Viral vectors for gene transfer: current status of gene therapeutics, Handb Exp Pharmacol, 143, 10.1007/978-3-642-00477-3_5 Bergelson, 1997, Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5, Science, 275, 1320, 10.1126/science.275.5304.1320 Pearson, 1999, Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines, Clin Cancer Res, 5, 4208 Alemany, 2009, Designing adenoviral vectors for tumor-specific targeting, Methods Mol Biol, 542, 57 Kurokawa, 2003, Heparanase and tumor invasion patterns in human oral squamous cell carcinoma xenografts, Cancer Sci, 94, 277, 10.1111/j.1349-7006.2003.tb01433.x Geiger, 2009, Metastasis mechanisms, Biochim Biophys Acta, 1796, 293 Katayama, 2003, Laminin gamma2-chain fragment in the circulation: a prognostic indicator of epithelial tumor invasion, Cancer Res, 63, 222 Qian, 2010, Macrophage diversity enhances tumor progression and metastasis, Cell, 141, 39, 10.1016/j.cell.2010.03.014 Patarroyo, 2002, Laminin isoforms in tumor invasion, angiogenesis and metastasis, Semin Cancer Biol, 12, 197, 10.1016/S1044-579X(02)00023-8 Mareel, 2009, Cancer invasion and metastasis: interacting ecosystems, Virchows Arch, 454, 599, 10.1007/s00428-009-0784-0 Kleinman, 2001, Invasion assays, Curr Protoc Cell Biol, 10.1002/0471143030.cb1202s00 Jackson, 2005, KAI1 tetraspanin and metastasis suppressor, Int J Biochem Cell Biol, 37, 530, 10.1016/j.biocel.2004.08.009 Tonoli, 2005, CD82 metastasis suppressor gene: a potential target for new therapeutics?, Trends Mol Med, 11, 563, 10.1016/j.molmed.2005.10.002 Liu, 2006, KAI1/CD82, a tumor metastasis suppressor, Cancer Lett, 240, 183, 10.1016/j.canlet.2005.08.018 Zhang, 2006, Intracellular sphingosine 1-phosphate mediates the increased excitability produced by nerve growth factor in rat sensory neurons, J Physiol, 575, 101, 10.1113/jphysiol.2006.111575 Johnstone, 2007, Epidermal growth factor and sphingosine-1-phosphate stimulate Na+/H+ exchanger activity in the human placental syncytiotrophoblast, Am J Physiol Regul Integr Comp Physiol, 293, R2290, 10.1152/ajpregu.00328.2007 Chandru, 2007, The role of sphingosine 1-phosphate in the TNF-alpha induction of IL-8 gene expression in lung epithelial cells, Gene, 391, 150, 10.1016/j.gene.2006.12.011 Buehrer, 1996, Protein kinase C-dependent regulation of human erythroleukemia (HEL) cell sphingosine kinase activity, Biochim Biophys Acta, 1303, 233, 10.1016/0005-2760(96)00092-6 Duan, 2006, Shp-2 tyrosine phosphatase is required for hepatocyte growth factor-induced activation of sphingosine kinase and migration in embryonic fibroblasts, Cell Signal, 18, 2049, 10.1016/j.cellsig.2006.04.002 Bottaro, 1991, Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product, Science, 251, 802, 10.1126/science.1846706 Ide, 2007, The hypoxic environment in tumor-stromal cells accelerates pancreatic cancer progression via the activation of paracrine hepatocyte growth factor/c-Met signaling, Ann Surg Oncol, 14, 2600, 10.1245/s10434-007-9435-3 Tanimura, 2002, Prolonged nuclear retention of activated extracellular signal-regulated kinase 1/2 is required for hepatocyte growth factor-induced cell motility, J Biol Chem, 277, 28256, 10.1074/jbc.M202866200 Dong, 2001, Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma, Cancer Res, 61, 5911 Sridhar, 2006, Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases, Oncogene, 25, 2367, 10.1038/sj.onc.1209269 Choi, 2009, KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells, Cell Biochem Funct, 27, 40, 10.1002/cbf.1532